期刊： PHARMACOGENOMICS, 2021; 22 (11)
Aim: The prognosis of resectable pancreatic cancer patients with the same stage of disease is highly variable. The purpose of this study is to establi......
期刊： PHARMACOGENOMICS, 2021; 22 (8)
Aim: The ERBB gene family plays an important role in cell proliferation and differentiation, and aberrant activations could result in tumorigenesis, w......
期刊： PHARMACOGENOMICS, 2021; 22 (10)
Aim: The aim of this study was to assess the association between PEAR1 polymorphisms and ischemic clinical outcomes. Materials & methods: We searc......
期刊： PHARMACOGENOMICS, 2021; 22 (04)
Background: Pharmacogenetics study was added into 2 bioequivalence trials of aripiprazole. The correlation between CYP2D6 polymorphisms and aripiprazo......
期刊： PHARMACOGENOMICS, 2020; 21 (12)
Aim: This study was conducted to investigate the effects of VKORC1, CYP2C9, CYP4F2 and EPHX1 and non-genetic factors on warfarin maintenance dose in a......
期刊： PHARMACOGENOMICS, 2020; 21 (13)
This network meta-analysis was conducted to compare the predictive value of eight SNPs on the efficacy of antidepressants in major depressive disorder......
期刊： PHARMACOGENOMICS, 2020; 21 (13)
Background:The pharmacogenomics and pharmacokinetics/pharmacodynamics of 400 mg efavirenz have rarely been reported.Materials & methods:A total of......
期刊： PHARMACOGENOMICS, 2020; 21 (2)
Aim: Major drawbacks of percutaneous coronary intervention are the high occurrence of repeat revascularization due to restenosis and disease progressi......
期刊： PHARMACOGENOMICS, 2020; 21 (2)
Aim: To analyze the impact of nongenetic factors and gene polymorphisms on warfarin dose requirements in elderly Shanghai Han Chinese patients. Materi......
期刊： PHARMACOGENOMICS, 2020; 21 (1)
Aim: To assess the cost-effectiveness of CYP2D6*10 genetic testing for the management of Chinese women with hormone receptor-positive (HR+) breast can......
期刊： PHARMACOGENOMICS, 2020; 21 (1)
Aim: This study aimed to evaluate the cost-effectiveness of CYP2C19 loss-of-function(LOF) allele-guided antiplatelet therapy compared with the univers......
期刊： PHARMACOGENOMICS, 2020; 21 (1)
Aim: To compare the prediction performance of different warfarin dosing algorithms based on Chinese patients. Materials & methods: A total of 18 a......
期刊： PHARMACOGENOMICS, 2020; 21 (3)
Aim: To evaluate the clinical benefits of implementing pharmacogenomics testing for Chinese pediatric patients. Materials & methods : Based on the......
期刊： PHARMACOGENOMICS, 2020; 21 (3)
Aim: miR-137 is downregulated in various cancers; however, its function in ovarian cancer remains unclear. Methods: The roles of miR-137 in apoptosis ......
